Introduction
Materials and methods
Patients and tissue samples
Features | No. of cases | miR-22 expression | P | |
---|---|---|---|---|
High | Low | |||
Age (years)
| 98 | 62.8 ± 23.2 | 62.1 ± 23.9 | NS |
Gender
| ||||
Male | 62 (63.3) | 25 (40.3) | 37 (59.7) | NS |
Female | 36 (36.7) | 15 (41.7) | 21 (58.3) | |
Histopathological type
| ||||
Intestinal type
| ||||
pap | 5 (5.1) | 2 (40.0) | 3 (60.0) | NS |
tub1 | 20 (20.4) | 9 (45.0) | 11 (55.0) | |
tub2 | 25 (25.5) | 8 (32.0) | 17 (68.0) | |
Diffuse type
| ||||
por1 | 15 (15.3) | 6 (40.0) | 9 (60.0) | NS |
por2 | 33 (33.7) | 15 (45.5) | 18 (54.5) | |
Tumor depth (pT)
| ||||
pT1 | 40 (40.8) | 20 (50.0) | 20 (50.0) | NS |
pT2 | 30 (30.6) | 10 (33.3) | 20 (66.7) | |
pT3 | 20 (20.4) | 8 (40.0) | 12 (60.0) | |
pT4 | 8 (8.2) | 2 (25.0) | 6 (75.0) | |
Lymph node metastasis (pN)
| ||||
pN0 | 50 (51.0) | 27 (54.0) | 23 (46.0) | 0.02 |
pN1 | 20 (20.4) | 8 (40.0) | 12 (60.0) | |
pN2 | 15 (15.3) | 4 (26.7) | 11 (73.3) | |
pN3 | 13 (13.3) | 1 (7.7) | 12 (92.3) | |
Distant metastasis (pM)
| ||||
pM0 | 86 (87.8) | 39 (45.3) | 47 (54.7) | 0.01 |
pM1 | 12 (12.2) | 1 (8.3) | 11 (91.7) | |
pStage
| ||||
I | 50 (51.0) | 29 (58.0) | 21 (42.0) | 0.02 |
II | 15 (15.3) | 5 (33.3) | 10 (66.7) | |
III | 20 (20.4) | 5 (25.0) | 15 (75.0) | |
IV | 13 (13.3) | 1 (7.7) | 12 (92.3) | |
Lymphatic invasion
| ||||
Negative | 45 (45.9) | 17 (37.8) | 28 (62.2) | NS |
Positive | 53 (54.1) | 23 (43.4) | 30 (56.6) | |
Venous invasion
| ||||
Negative | 68 (69.4) | 23 (33.8) | 45 (66.2) | NS |
Positive | 30 (30.6) | 17 (56.7) | 13 (43.3) | |
Hematogenous recurrence
| ||||
Negative | 78 (79.6) | 32 (41.0) | 46 (59.0) | NS |
Positive | 20 (20.4) | 8 (40.0) | 12 (60.0) |
Quantitative RT-PCR
Statistical analysis
Results
Reduced expression of microRNA-22 is associated with advanced clinicopathologic characteristics of patients with gastric cancer
Reduced expression of microRNA-22 confers poor prognosis in patients with gastric cancer
Independent factors | Univariate P | Multivariate P | Hazard ratio | 95% confidence interval |
---|---|---|---|---|
Tumor depth (pT)
| ||||
pT1 and pT2/pT3 and pT4 | 0.006 | 0.01 | 3.8 | 1.0 ~ 7.2 |
Lymph node metastasis (pN)
| ||||
Negative/positive | 0.001 | 0.01 | 4.1 | 1.2 ~ 8.9 |
Venous invasion
| ||||
Negative/positive | 0.03 | NS | 1.8 | 0.5 ~ 3.1 |
pStage
| ||||
I and II and III and IV | 0.03 | NS | 1.2 | 0.09-2.3 |
miR-22 expression
| ||||
Negative/positive | 0.03 | 0.04 | 2.2 | 0.6 ~ 5.2 |